NEVVI Medicare utilization intelligence

← back

Provider profile

REGILLO, CARL MD

Ophthalmology · NPI 1740248038 · PLYMOUTH MEETING, PA

2
Groups
21
Codes · 2024
72,266
Disclosed services

REGILLO, CARL is a Ophthalmology in PLYMOUTH MEETING, PA, a member of 2 medical groups, who billed 21 distinct codes to Medicare Part B in 2024.

Groups: ASSOCIATED RETINAL SURGEONS, PA (CHERRY HILL, NJ) · RETINOVITREOUS ASSOCIATES LTD (PHILADELPHIA, PA) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider analytics (2024)

REGILLO, CARL billed 54,345 disclosed services in CY2023 and 72,266 in CY2024.

This provider's disclosed Medicare payments across all codes were $premium in CY2024.

The full figure is part of the market analytics platform — built, not launched yet. Notify me at launch →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J2777 Injection, faricimab-svoa, 0.1 mg premiumpremium premiumpremium
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg premiumpremium premiumpremium
92134 Imaging of retina premiumpremium premiumpremium
J2781 Injection, pegcetacoplan, intravitreal, 1 mg premiumpremium premiumpremium
67028 Injection of drug into eye premiumpremium premiumpremium
92012 Established patient problem focused exam of visual system premiumpremium premiumpremium
J2782 Injection, avacincaptad pegol, 0.1 mg premiumpremium premiumpremium
J0178 Injection, aflibercept, 1 mg premiumpremium premiumpremium
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg premiumpremium premiumpremium
92014 Established patient complete exam of visual system premiumpremium premiumpremium
J0177 Injection, aflibercept hd, 1 mg premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
J3590 Unclassified biologics premiumpremium premiumpremium
92201 Extended exam of the back part of the eye with retinal drawing premiumpremium premiumpremium
J7999 Compounded drug, not otherwise classified premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
76512 2d ultrasound scan of eye tissue and structures premiumpremium premiumpremium
92250 Photography of the retina premiumpremium premiumpremium
67042 Removal of membrane of retina with removal of internal limiting membrane of retina premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
67145 Photocoagulation treatment to prevent detachment of retina premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.